Abstract
The BCCIPα protein was identified as a BRCA2 and CDKN1A (p21, or p21Waf1/Cip1) Interacting Protein. It binds to a highly conserved domain proximate to the C-terminus of BRCA2 protein and the C-terminal domain of the CDK-inhibitor p21. Previous reports showed that BCCIPα enhances the inhibitory activity of p21 toward CDK2 and that BCCIPα inhibits the growth of certain tumor cells. Here we show that a second isoform, BCCIPβ, also binds to p21 and inhibits cell growth. The growth inhibition by BCCIPβ can be partially abrogated in p21 deficient cells. Overexpression of BCCIPβ delays the G1 to S progression and results in an elevated p21 expression. These data suggest BCCIPβ as a new regulator for the G1-S cell cycle progression and cell growth control. ©2004 Landes Bioscience.
Cite
CITATION STYLE
Meng, X., Liu, J., & Shen, Z. (2004). Inhibition of G1 to S cell cycle progression by BCCIPβ. Cell Cycle, 3(3), 341–346. https://doi.org/10.4161/cc.3.3.672
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.